Navigation Links
Cardiogenesis Announces Addition of Raymond W. Cohen to Board of Directors
Date:12/2/2008

IRVINE, Calif., Dec. 2 /PRNewswire-FirstCall/ -- Cardiogenesis Corporation (Pink Sheets: CGCP), a leading developer of surgical products used in the treatment of patients suffering from severe angina, today announced the addition of veteran medical device executive and an experienced public company director, Raymond W. Cohen as a member of the Company's Board of Directors, increasing the number of board members to six.

Mr. Cohen, 49, has over 25 years of executive experience in the medical technology field and is currently the Chief Executive Officer and a member of the Board of Directors of Symphony Medical Inc., a venture-capital backed developer of novel biotherapeutic therapies to treat heart failure and other cardiac abnormalities.

For the decade prior to 2006, Cohen served as Chairman and CEO of publicly traded Cardiac Science, Inc. having served in that role during the period of rapid revenue growth and through the company's merger with Quinton Cardiology in late 2005. Today Cardiac Science is a leading manufacturer of automated public-access defibrillators and diagnostic cardiology systems, generating over $200 million in annual revenue. Cohen continues to serve on the board of Cardiac Science and also serves on the boards of BioLife Solutions, Inc., a publicly traded company, and BioGenex, Inc., and Syncroness, Inc.

Paul J. McCormick, the Company's Chairman of the Board commented, "Mr. Cohen has a solid track record of success in developing and commercializing innovative medical technology, particularly in the cardiovascular market. He brings the vision, insight and skills necessary to make a significant contribution to the Cardiogenesis Board of Directors and our shareholders. We are very pleased to have Mr. Cohen join our board and look forward to working with him."

About Cardiogenesis Corporation

Cardiogenesis specializes in provi
'/>"/>

SOURCE Cardiogenesis Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Cardiogenesis Reports Third Quarter 2008 Results
2. Cardiogenesis Reports Fourth Quarter and Full Year 2007 Results
3. Cardiogenesis Corporation to Report Third Quarter 2007 Results on November 14th
4. Encorium Announces Receipt of Letter from Nasdaq Regarding its Third Quarter 2008 Form 10-Q Filing
5. Kiadis Pharma Announces Continued Collaboration With Professor Velardi on its Lead Product ATIR(TM)
6. Therapure Biopharma Inc. Announces Manufacturing Agreement with Biomedical Frontiers Incorporated -- Contract will Support Phase II Trials for Thalassemia Treatment
7. Rosetta Genomics Announces Conference Call and Webcast of Third Quarter Financial Results
8. Ceregene Announces Clinical Data From Phase 2 Clinical Trial of CERE-120 for Parkinsons Disease
9. Sosei Announces the Out-licensing of RS(+) Mefloquine to Treague Ltd for the Treatment and Prophylaxis of Malaria
10. Genoptix Announces Participation at the Twentieth Annual Piper Jaffray Healthcare Conference
11. Indevus Pharmaceuticals Announces Fiscal 2008 Year End and Fourth Quarter Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)... Biotech firm Replikins Ltd., whic...he 1918 pandemic through the prediction, outbreak,...issued its latest biochemical analysis of the viru...N1 ("Swine Flu") virus has dropped from its peak o...ak in the spring of 2009 to resting non-epidemic l...
(Date:11/25/2009)...25 Reportlinker.com announces that...catalogue: ,, Brazil Bioethanol Market Analysi...inker.com/p0165503/Brazil-Bioethanol-Market-Analys...anol Market Analysis and Forecasts to 2013 ,, ...is and forecasts of the global bioethanol market a...
(Date:11/24/2009)... York investment bank KTA Capital,s client Neuren ... mil convertible note private placement with a U.S...s arranged by KTA Capital as Neuren,s exclusive pl... New York (PRWEB) November 23, 2009 -- The inde...("KTA Capital") has announced that its c...
(Date:11/24/2009)... care employment grew by 29,000 jobs in October, ...ent growth during the U.S. recession. However, cli...d health systems are coming closer to having to ac...nistrators. , (Vocus) Nov... growing in October despite the shedding of jobs i...
Breaking Biology Technology:Biological H1N1 Vaccines: Too Little, Too Late 2Biological H1N1 Vaccines: Too Little, Too Late 3Biological H1N1 Vaccines: Too Little, Too Late 4Biological H1N1 Vaccines: Too Little, Too Late 5Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 2Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 3Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 4Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 5Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 6Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 7Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 8Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 9Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 10KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4
..., May 19 MedClean Technologies, Inc. (OTC Bulleti...ed a private offer to exchange all of the Company,...tial Exercise Dates between July 11, 2008 and Augu... Common Stock Purchase Warrants, with a new lower ...ares of our common stock, par value $0.0001 per sh...
...., May 19 In an eleventh-hour attempt to smear T...Y ) has issued a press release claiming that there...r. Richard Rosenbloom, a key staff member of a sub...a group of dissident shareholders who have offered...or election at the annual meeting scheduled for We...
...hina, May 19 /PRNewswire-Asia-FirstCall/ -- China ...the Company") (Nasdaq: CSKI ), a leading,fully i...e-counter drugs in,the People,s Republic of China ...rhouse Coopers ("PWC") to assist the Company in co...equirements of Sarbanes-Oxley Act Section 404,("SO...
Other Biology Technology:MedClean Technologies, Inc. Announces Private Offer to Exchange Warrants 2MedClean Technologies, Inc. Announces Private Offer to Exchange Warrants 3MedClean Technologies, Inc. Announces Private Offer to Exchange Warrants 4In Eleventh-Hour Smear Attempt, Quigley Management Sacrifices Key Employee of its Pharma Division 2In Eleventh-Hour Smear Attempt, Quigley Management Sacrifices Key Employee of its Pharma Division 3China Sky One Medical, Inc. Appoints Pricewaterhouse Coopers to Help Develop a SOX 404 Compliance Program 2China Sky One Medical, Inc. Appoints Pricewaterhouse Coopers to Help Develop a SOX 404 Compliance Program 3
(Date:11/26/2009)..., Heidelberg, 27 November 2009 What are the ba...ts required to produce a cell that can survive on ...a cell, and understand how an entire organism func...tions that scientists in a partnership between the...eidelberg, Germany, and the Centre de Regulacio Ge...
(Date:11/25/2009)... On September 11, firefighters, police officers an...rt in the World Trade Center complex. They battled...earched for survivors, tackled fires and evacuated...tained an estimated 17,000 people. And making thei...cations: frightened workers and their relatives ja...
(Date:11/25/2009)..., LA JOLLA, CAWhen you eat may be just as vital t...t the Salk Institute for Biological Studies. Their...g and waning of thousands of genes in the liverthe...d by food intake and not by the body,s circadian c...ng time determines the activity of a large number ...
Breaking Biology News(10 mins):First-ever blueprint of a minimal cell is more complex than expected 2First-ever blueprint of a minimal cell is more complex than expected 3Magic box for mission impossible 2Magic box for mission impossible 3Feeding the clock 2Feeding the clock 3Oxygen Biotherapeutics Inc to Present at Investment Conferences in New York and Zurich 13695 1Oxygen Biotherapeutics Inc to Present at Investment Conferences in New York and Zurich 13695 2NIAID Awards New Grant to Expand Studies of Peregrines Anti PS Antibodies to Treat Viral Hemorrhagic Fevers 55384 1NIAID Awards New Grant to Expand Studies of Peregrines Anti PS Antibodies to Treat Viral Hemorrhagic Fevers 55384 2NIAID Awards New Grant to Expand Studies of Peregrines Anti PS Antibodies to Treat Viral Hemorrhagic Fevers 55384 3NIAID Awards New Grant to Expand Studies of Peregrines Anti PS Antibodies to Treat Viral Hemorrhagic Fevers 55384 4NIAID Awards New Grant to Expand Studies of Peregrines Anti PS Antibodies to Treat Viral Hemorrhagic Fevers 55384 5American Brain Tumor Association Statement on the Death of U S Senator Edward M Kennedy 55380 1
...reasing attention given to the potential of biocha... wood) to serve as a long term sink of carbon in t...nd breaks down extremely slowly, persisting in soi...estion being seriously considered by policy makers... quantities and stored in soils. This would in tur...
... in French . , Canadian, French and British re...rols the variability of blood glucose levels in pe...because high blood glucose levels in otherwise hea... and higher mortality rates. The results will be p...l Science. , The research was conducted by Dr. P...
...Texas The first year of ConocoPhillips [NYSE:COP]...a State University (ISU) has supported 26 research...orations to further diversify Americas sources of ...ocoPhillips, the third-largest integrated energy c...n to begin 14 research projects at ISU in 2007. Th...
Other Biology News:Limitations of charcoal as an effective carbon sink 2Genetic breakthrough explains dangerously high blood glucose levels 2Genetic breakthrough explains dangerously high blood glucose levels 3Iowa State-ConocoPhillips collaboration advances 26 research projects in first year 2
...CC1041 is a recombinant 177 amino acid polypeptide... human MT1-MMP. Produced by activation of a recom... coli periplasm. SPECIFIC ACTIVITY:The specific a..., where 1 U is the activity that hydrolyzes 1 mol ...
...The EC570-90 is a compact, lightweight, high curre...ts or 2500 milliamps. It is an excellent choice fo... is also ideal for all types of electroblotting ap...t to automatically end a run and wil automatically...
Anti-Interferon-beta (IFNb) Monoclonal Antibody, Unconjugated from CHEMICON
...For use in Refrigerated Vapor Trap Models RVT100, ...urce (UVS) Models UVS400, UVS400A and UVS800DDA.,...licone polymer suitable for use for temperatures r... has excellent thermal stability and does not evap...
Biology Products: